RecruitingNot ApplicableNCT06182683

Concurrent OCT and FFR-guided PCI in CAD

Concurrent OPTIcal Coherence Tomography and frActional Flow REserve-guided Therapeutic Intervention in Patients With Coronary Artery Disease (OPTICARE-CAD)


Sponsor

Korea University Guro Hospital

Enrollment

700 participants

Start Date

Nov 30, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The present study is a prospective randomized clinical trial aimed to compare the therapeutic strategy of angiography-guided versus concurrent OCT/FFR-guided intervention in patients with coronary artery disease.


Eligibility

Min Age: 19 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Coronary angiography and optical coherence tomography and fractional flow reserve for people with atheroscleroses, coronary, coronary artery disease, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 19 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESToptical coherence tomography and fractional flow reserve

The assessment of pre-procedural lesions and optimization status of implanted stents will involve both intracoronary imaging and physiological indices.

DIAGNOSTIC_TESTCoronary angiography

The assessment of pre-procedural lesions and optimization status of implanted stents will be determined by conventional coronary angiography


Locations(1)

Korea University Guro Hospital

Seoul, South Korea

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06182683


Related Trials